Biotech PR agency that helps investors, partners, and the scientific community understand and believe in your science.
Our clients have been featured in










Biotech stories live or die on accuracy. Reporters need the science explained without hype, investors want milestones and a clear path to market, and partners want to know your team can execute. We turn platform technology and pipeline progress into accurate, compelling coverage that supports fundraising and partnering.
Life sciences and biotech trade media, business and investor outlets, science journalism, and industry podcasts.

Editors don't cover companies. They cover stories. These are the angles we build most often for biotech companies:
Biotechs need capital, partners, and talent, and all three follow visibility. Clear coverage of your science and team in life sciences and business media builds the credibility that supports financing and partnerships.
See our media relations, thought leadership, and AEO services, or compare plans from $4,000/month.
Yes. Building visibility with founder interviews and expert commentary before a raise makes investor conversations warmer.
Only data that is already public and approved by your team. We never pitch unpublished or forward-looking clinical claims.
We translate your science into clear stories about the problem, the approach, and why it matters, and review every detail with your scientists for accuracy.
Our monthly plans start at $4,000. We recommend the right plan on the first call, based on your goals.
Ready to elevate your story, sharpen your strategy, and get the attention you deserve?
Book a 20-minute consultation. We'll review your goals and map the stories and outlets that fit your business.
Book a free consultationPrefer email? Send us a note.